EVOQ Therapeutics is developing immunotherapies to improve the lives of individuals fighting autoimmune diseases.
There are more than 100 chronic autoimmune diseases - many severely debilitating, and some life-threatening. According to the National Institutes of Health, up to 23.5 million Americans (over 7% of the population) suffer from autoimmune disease, and the prevalence is rising.
Autoimmune disease occurs when the body’s central immune tolerance system fails - resulting in T and B cell-mediated destruction of self-tissues. This immune system failure is responsible for many devastating diseases including – Type 1 Diabetes, Celiac disease, Multiple sclerosis and Rheumatoid Arthritis.
EVOQ’s technology unleashes and restores the body’s natural immune tolerance pathways.
Company Details
- Employees
- 9
- Address
- 1600 Huron Parkway, Bldg 420
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- evoqtherapeutics.com
- HQ
- Ann Arbor, Michigan
Evoq Therapeutics Questions
Evoq Therapeutics's website is evoqtherapeutics.com
Evoq Therapeutics's LinkedIn profile is https://www.linkedin.com/company/evoq-therapeutics
Evoq Therapeutics has
9 employees.
View email and phone details for 9
employees at Evoq Therapeutics.
Evoq Therapeutics's industry is
Biotechnology Research
Evoq Therapeutics's top competitors are
Mdi Therapeutics, Inc.,
Exicure,
M3d,
Anchorbio Solutions,
Intero Biosystems,
Onl Therapeutics,
Saros Therapeutics,
Blue Arbor Technologies, Inc.,
Akadeum Life Sciences, Inc.,
Histosonics, Inc..
Evoq Therapeutics's support email address is info@evoqtherapeutics.com
Evoq Therapeutics's categories are Biotechnology Research
